Dear Sir, I read with interest the study by Omote et al. [1] published in the September-December 2018 issue of the Saudi Journal for Health Sciences. The authors studied the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among patients seen in a tertiary health facility in Jalingo, Taraba state, Nigeria. They found that 13.6%, 16.6%, and 1% were positive of HBV, HCV, and coinfection, respectively. [1] I presume that the following methodological limitation might cast some suspicions on the accuracy of the study results. It is explicit that there are bidirectional relationships between human immunodeficiency virus (HIV) and several sexually transmitted infections, including HBV and HCV. On the one hand, HIV might affect the clinical picture, treatment outcome, and progression of HBV and HCV. On the other hand, the presence of HBV and HCV infections might increase both genital and plasma HIV ribonucleic acid (RNA) levels and thus, augment the transmission of HIV infection. [2] Nigeria is one of the Sub-Saharan countries substantially affected with HIV epidemic. The recently published data pointed out to 12.9% HIV seroprevalence in Nigeria with urban/ rural disparity. [3] The coinfections of HIV, HBV, and HCV are worrisome health issue in Nigeria where the seroprevalences of HBV/HCV, HIV/HBV, HIV/HCV, and HIV/HBV/HCV coinfection were 1.3%, 1.3%, 1.5%, and 0.4%, respectively. [3] Defining HIV status in the studied cohort in Omote et al.'s study [1] by the diagnostic algorithm of viral overload and CD4 lymphocyte count estimations would have envisaged. Hence, HIV positivity ought to be considered an important exclusion criterion in the study methodology.
